| Literature DB >> 22409839 |
Katleen Vranckx1, Dominiek Maes, Silvana B Marchioro, Iris Villarreal, Koen Chiers, Frank Pasmans, Freddy Haesebrouck.
Abstract
BACKGROUND: Mycoplasma hyopneumoniae is the causative agent of enzootic pneumonia and is responsible for significant economic losses to the pig industry. To better understand the mode of action of a commercial, adjuvanted, inactivated whole cell vaccine and the influence of diversity on the efficacy of vaccination, we investigated samples from vaccinated and non-vaccinated pigs experimentally infected with either a low (LV) or a highly virulent (HV) M. hyopneumoniae strain. Non-vaccinated and sham-infected control groups were included. Lung tissue samples collected at 4 and 8 weeks post infection (PI) were immunohistochemically tested for the presence of T-lymphocytes, B-lymphocytes and macrophages in the bronchus-associated lymphoid tissue (BALT). The number of M. hyopneumoniae organisms in bronchoalveolar lavage (BAL) fluid was determined using quantitative PCR at 4 and 8 weeks PI. Serum antibodies against M. hyopneumoniae were determined at 0, 2, 4, 6 and 8 weeks PI.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22409839 PMCID: PMC3349615 DOI: 10.1186/1746-6148-8-24
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Scoring of the presence of macrophages, T- lymphocytes and B-lymphocytes in bronchus-associated lymphoid tissue (BALT) and the number of M. hyopneumoniae organisms (log) in the bronchoalveolar lavage (BAL) fluid1
| Score T-lymphocytes (0-3) | Score B-lymphocytes (0-3) | |||||||
|---|---|---|---|---|---|---|---|---|
| 1.0 ± 0.0 | 0.0 ± 0.0 | 0.5 ± 0.5 | 0.5 ± 0.5 | 0.0 ± 0.0a, b | 0.3 ± 0.2 | -0.76 ± 0.21a | -0.69 ± 0.41a | |
| 1.2 ± 0.2 | 0.5 ± 0.5 | 2.0 ± 0.5 | 0.8 ± 0.7 | 0.7 ± 0.5a, b | 1.3 ± 0.8 | 1.25 ± 0.74a, b | 2.41 ± 0.59b | |
| 1.4 ± 0.2 | 1.2 ± 0.3 | 2.8 ± 0.2 | 1.6 ± 0.3 | 1.6 ± 0.9b | 1.0 ± 0.4 | 3.44 ± 0.35b | 1.89 ± 0.71a, b | |
| 0.8 ± 0.4 | 0.5 ± 0.2 | 1.4 ± 0.6 | 0.9 ± 0.2 | 0.0 ± 0.0a | 0.1 ± 0.1 | 0.97 ± 0.53a, c | 2.29 ± 0.39b | |
| 1.0 ± 0.3 | 1.0 ± 0.2 | 1.6 ± 0.4 | 1.5 ± 0.2 | 0.0 ± 0.0a | 0.2 ± 0.1 | 1.96 ± 0.43b, c | 1.80 ± 0.48b | |
nv non-vaccinated; v vaccinated; LV low virulent challenge strain; HV highly virulent challenge strain
1 Scoring was performed on samples of vaccinated and non-vaccinated pigs at 4 and 8 weeks after endotracheal inoculation with a low or highly virulent M. hyopneumoniae strain. A non-vaccinated and non- infected control group was also included.
2 Different lowercase letters correspond to significantly different values between the groups within a column
Number of pigs with serum antibodies against M. hyopneumoniae (IDEXX M. hyo Elisa) and average (± SEM) S/P ratio at 0, 2, 4, 6 and 8 weeks post-inoculation (PI) in the different groups
| Weeks PI | |||||
|---|---|---|---|---|---|
| 0 | 2 | 4 | 6 | 8 | |
| 0/10 | 0/10 | 0/10 | 0/5 | 0/5 | |
| 0.05 ± 0.02a | 0.00 ± 0.02a | 0.12 ± 0.05a | 0.13 ± 0.09a | 0.13 ± 0.06a | |
| 0/20 | 1/20 | 14/20 | 8/10 | 8/10 | |
| 0.12 ± 0.03a | 0.12 ± 0.04a | 0.38 ± 0.07a, b | 0.59 ± 0.12a, b | 0.59 ± 0.12a | |
| 0/20 | 2/20 | 20/20 | 10/10 | 10/10 | |
| 0.15 ± 0.04a | 0.12 ± 0.04a | 0.61 ± 0.06b | 0.68 ± 0.10b | 0.67 ± 0.14a | |
| 19/20 | 19/20 | 19/10 | 10/10 | 10/10 | |
| 0.45 ± 0.06b | 0.84 ± 0.06b | 1.11 ± 0.08c | 1.20 ± 0.10c | 1.24 ± 0.11b | |
| 17/20 | 20/20 | 20/20 | 20/20 | 20/20 | |
| 0.46 ± 0.05b | 0.86 ± 0.06b | 1.14 ± 0.09c | 1.24 ± 0.09c | 1.26 ± 0.09b | |
nv non-vaccinated; v vaccinated; LV low virulent challenge strain; HV high virulent challenge strain
Different lowercase letters correspond to significantly different values between the groups at one time point Pigs were vaccinated three weeks before inoculation
Spearman correlation coefficients between the different parameters investigated in this study1
| Log qPC R | T- lymphocytes | B- lymphocytes | Macrophages | IF | Micro LLS | Macro LLS | ||
|---|---|---|---|---|---|---|---|---|
| 0 | -0.06 | -0.06 | -0.31 | -0.52* | 0.17 | -0.02 | -0.34* | |
| 0.24 | -0.09 | -0.03 | -0.49* | 0.17 | 0.26 | 0.19 | ||
| 2 | 0.13 | 0.02 | -0.31 | -0.53* | 0.03 | 0.01 | -0.26 | |
| 0.33* | 0.19 | 0.13 | -0.37 | 0.15 | 0.33* | 0.22 | ||
| 4 | 0.20 | 0.02 | -0.11 | -0.19 | 0.17 | 0.25 | -0.01 | |
| 0.27 | 0.32 | 0.22 | -0.29 | 0.01 | 0.45** | 0.20 | ||
| 6 | - | - | - | - | - | - | - | |
| 0.38* | 0.57* | 0.42 | -0.07 | 0.08 | 0.41** | 0.25 | ||
| 8 | - | - | - | - | - | - | - | |
| 0.43** | 0.68** | 0.52* | -0.04 | 0.12 | 0.46** | 0.29 | ||
| 0.33 | 0.48* | 0.63* | 0.08 | 0.62** | 0.52** | |||
| 0.33 | 0.36 | 0.45 | 0.30* | 0.28 | 0.39* | |||
| 0.40 | 0.30 | 0.15 | 0.24 | 0.50* | ||||
| 0.83** | 0.37 | 0.15 | 0.66** | 0.60* | ||||
| 0.76** | 0.02 | 0.56** | 0.50* | |||||
| 0.39 | 0.26 | 0.55** | 0.53* | |||||
| -0.02 | 0.67** | 0.67** | ||||||
| 0.24 | 0.11 | -0.04 | ||||||
| 0.24 | 0.13 | |||||||
| 0.31* | 0.44** | |||||||
| 0.67** | ||||||||
| 0.43** |
* p < 0.05; ** p < 0.01
1 antibody titer (SP ratio of the serology), the scoring of immune cells (T-lymphocytes, B-lymphocytes and macrophages), immunofluorescence staining for M. hyopneumoniae (IF) and the microscopic and macroscopic lung lesion score (LLS) at the level of the individual pig at 4 (top) and 8 (bottom) weeks post-infection
Immunofluorescence score (IF), microscopic and macroscopic lung lesion score (LLS)1
| IF | Microscopic LLS | Macroscopic LLS | ||||
|---|---|---|---|---|---|---|
| Scores | (0-3) | (0-5) | (0-35) | |||
| 0.00 ± 0.00a | 0.00 ± 0.00a | 1.17 ± 0.08a | 1.17 ± 0.13a | 0.00 ± 0.00a | 0.00 ± 0.00a | |
| 0.77 ± 0.20a, b | 1.33 ± 0.20b, c | 2.90 ± 0.26b | 2.92 ± 0.15b | 2.38 ± 1.20a, b | 1.20 ± 0.30a | |
| 1.26 ± 0.27b | 1.44 ± 0.28b | 4.04 ± 0.15c | 3.62 ± 0.15b | 6.69 ± 1.70b | 5.60 ± 1.20b | |
| 0.90 ± 0.21a, b | 1.33 ± 0.13b, c | 3.10 ± 0.16b | 3.41 ± 0.17b | 0.93 ± 0.90a | 1.74 ± 0.40a | |
| 0.80 ± 0.11a, b | 0.67 ± 0.14a, c | 3.02 ± 0.09b | 3.35 ± 0.07b | 0.11 ± 0.07a | 1.99 ± 0.60a | |
nv non-vaccinated; v vaccinated; LV low virulent challenge strain; HV highly virulent challenge strain
1 Scoring was performed in vaccinated and non-vaccinated pigs at 4 and 8 weeks after endotracheal inoculation with a low or highly virulent M. hyopneumoniae strain. A non-vaccinated and non- infected control group was also included. The parameters were determined in the study of Villarreal et al. (2011) [11] and included in the statistical analysis of the present study.